medigraphic.com
ISSN 1561-3119 (Electronic)

2019, Number 1

<< Back Next >>

Rev Cubana Pediatr 2019; 91 (1)

Risk factors and bronchopulmonary dysplasia in very low weight premature infants

Zavaleta-Gutierrez FE, Concepción-Urteaga LA, Concepción-Zavaleta MJ, Aguilar-Villanueva DA

Language: Spanish
References: 38
Page: 1-16
PDF size: 197.78 Kb.


ABSTRACT

Introduction: Bronchopulmonary dysplasia is the most common sequelae related to very low birth weight premature infants, and it is derived from pulmonary immaturity and in some cases from treatment.
Objective: To identify maternal and neonatal risk factors associated with bronchopulmonary dysplasia in very low birth weight premature infants.
Methods: The sample was composed of 205 very low birth weight premature infants at Belén of Trujillo Hospital during the period 2008-2015. The group of cases and controls were 41 patients with diagnosis of bronchopulmonary dysplasia and 164 patients with no diagnosis of this respiratory disorder, respectively, and that both groups adjusted with exclusion criteria.
Results: Risk factors associated with bronchopulmonary dysplasia were 2 or more episodes of late onset sepsis (OR=5.12; IC95 %: 1,87-14,06), extreme prematurity (OR= 4.86; IC95 %: 1.7-13.80), extremely low birth weight (OR= 2.72; IC95 %: 0.9-7.94) and neonatal resuscitation (OR= 2.28; IC95%: 0.89-5.87).
Conclusions: Extreme prematurity and 2 or more episodes of late onset sepsis were the most associated risk factors to the onset of bronchopulmonary dysplasia in very low birth weight premature infants.


REFERENCES

  1. Torres Muñoz J. Características de neonatos con displasia broncopulmonar del Hospital Universitario del Valle Evaristo García de Cali, Colombia. Rev Gastrohnup. 2013;15(1):S4-S9. Acceso: 19/05/2015. Disponible en: http://www.gastropediatria. org/a13v15n1s1/a13v15n1s1art1.pdf

  2. Tapia JL, Agost D, Alegria A, Standen J, Escobar M, Grandi C, et al. Bronchopulmonary displasia: incidence, risk factors and resource utilization in a population of South American very low birth weight infants. J Pediatr (Rio J). 2006;82:15-20. Acceso: 19/05/2015. Disponible en: http://www.scielo.br/scielo. php?pid=S0021-75572006000100005&script=sci_arttext

  3. Ruiz-Peláez JG, Charpak N. Bronchopulmonary dysplasia epidemic: incidence and associated factors in a cohort of premature infants in Bogotá, Colombia. Biomédica. 2014;34(1):29-39. Acceso: 10/10/2015. Disponible en: https://www.ncbi.nlm.nih. gov/pubmed/24967857

  4. BrenerDik PH, Niño Gualdron YM, Galletti MF, Cribioli CM, Mariani GL. Displasia broncopulmonar: incidencia y factores de riesgo. Arch Argentinos Pediatr. 2017;115(5):476-82. Acceso: 14/02/2018. Disponible en: http://www.scielo.org.ar/ scielo.php?pid=S0325-00752017000500012&script=sci_abstract&tlng=en

  5. Keszler M, Sant'Anna G. Mechanical ventilation and Bronchopulmonary Dysplasia. Clin Perinatol. 2015;42(4):781-96. Acceso: 11/09/2018. Disponible en: https://www. ncbi.nlm.nih.gov/pubmed/26593078

  6. Hernández-Ronquillo L, Téllez-Zenteno JF, Weder-Cisneros N, Salinas-Ramírez V, Zapata-Pallagi JA, Da Silva O. Risk factors for the development of bronchopulmonary displasia: a case-control study. Arch Med Res. 2004;35(6):549-53. Acceso: 04/06/2015. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/15631883?dopt= Abstract&holding=npg

  7. Klinger G, Sokolover N, Boyko V, Sirota L, Lerner-Geva L, Reichman B. Perinatal risk factors for bronchopulmonary dysplasia in a national cohort of very-lowbirthweight infants. Am J Obstet Gynecol. 2013; 208(2):115.e1-9. Acceso: 04/06/2015. Disponible en: https://europepmc.org/abstract/med/23178245

  8. Stucin I, Babnik J, Kornhauser L, Sinkovec J, Wraber B. Prenatal and postnatal risk factors of developing bronchopulmonary dysplasia. Signa Vitae. 2011;6(2):46-51. Acceso: 08/06/ 2015. Disponible en: http://www.signavitae.com/2011/10/prenatal-andpostnatal- risk-factors-for-developing-bronchopulmonary-dysplasia/

  9. Lall A, Prendergast M, Greenough A. Risk factors for the development of bronchopulmonary dysplasia: the role of antenatal infection and inflammation. Expert Rev Respirat Med. 2007;1(2):247-54. Acceso: 03/06/2015. Disponible en: https://doi.org/10.1586/17476348.1.2.247

  10. Hernández RL, Téllez ZJF, Salinas RV, Zapata PJA. Factores de riesgo para el desarrollo de displasia broncopulmonar neonatal en el Instituto Nacional de Perinatología. Bol Med Hosp Infant Mex. 2002;59(8):461-469. Acceso: 02/02/2016. Disponible en: http://www.imbiomed.com/1/1/articulos.php? method=show Detail&id_ articulo=4277&id_seccion=134&id_ejemplar=481&id_revista=20

  11. Yen T-A, Yang H-I, Hsieh W-S, Chou H-C, Chen C-Y, Tsou K-I, et al. Preeclampsia and the risk of bronchopulmonary dysplasia in VLBW Infants: A population based study. PLoS ONE. 2013; 8(9):e75168. Acceso: 10/10/2015. Disponible en: http://journals.plos.org/plosone/article?id= 10.1371/journal. pone.0075168

  12. O’Shea J, Davis P, Doyle L. Maternal preeclampsia and risk of bronchopulmonary dysplasia in preterm infants. Pediatric Res. 2012;71(2):210-4. Acceso: 10/10/2015. Disponible en: https://www.nature.com/articles/pr201127

  13. Cunha G, Mezzacappa Filho F, Ribeiro J. Fatores maternos e neonatales na incidȇncia de displasia broncopulmonar em recém de muitobaixo peso. J Pediatr. 2003;79(6):550-6. Acceso: 01/04/2016. Disponível em: http://www.scielo.br/scielo. php?pid=S0021-75572003000600015&script=sci_abstract&tlng=pt

  14. Papagianis PC, Pillow JJ, Moss TJ. Bronchopulmonary dysplasia: Pathophysiology and potential anti-inflammatory therapies. Paediatr Respir Rev. 2018; 18:30079-4. Acceso: 13/09/2018. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/30201135

  15. D'Angio CT, Ambalavanan N Carlo WA, McDonald SA, Skogstrand K, Hougaard DM, et al. Blood Cytokine Profiles Associated with Distinct Patterns of Bronchopulmonary Dysplasia among Extremely Low Birth Weight Infants. J Pediatr. 2016;174:45-51.e5. Acceso: 15/09/2018. Disponible en: https://www.ncbi.nlm.nih. gov/pubmed/27117196

  16. Kalikkot Thekkeveedu R, Guaman MC, Shivanna B. Bronchopulmonary dysplasia. A review of pathogenesis and pathophysiology. Respir Med. 2017; 132:170-7. Acceso: 11/09/2018. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/29229093.

  17. Torchin H, Ancel PY, Goffinet F, Hascoët JM, Truffert P, Tran D, et al. Placental Complications and Bronchopulmonary Dysplasia: EPIPAGE-2 Cohort Study. Pediatrics. 2016;137(3):1-10. Acceso: 11/09/2018. Disponible en: https://www.ncbi. nlm.nih.gov/pubmed/26908662

  18. Thomas W, Speer CP. Chorioamnionitis is essential in the evolution of bronchopulmonary dysplasia- The case in favour. Paediatr Respir Rev. 2014; 15(1):49- 52. Acceso: 01/03/2016. Disponible en: https://www.ncbi.nlm.nih.gov/ pubmed/24128984

  19. Sabogal C, Taimaciu I. Displasia broncopulmonar (desde el punto de vista del neumólogo). Rev peru pediatr. 2008;61(3):176-87. Acceso: 19/05/2015. Disponible en: http://sisbib.unmsm.edu.pe/BVRevistas/rpp/v61n3/pdf/a07v61n3.pdf

  20. Trembath A. Laughon M. Predictors of Bronchopulmonary Dysplasia. Clin Perinatol. 2012;39(3):585-601. Acceso: 06/01/2016. Disponible en: https://www.ncbi. nlm.nih.gov/pmc/articles/PMC3443959/

  21. Hilgendorff A, O´Reilly MA. Bronchopulmonary displasia early changes leading to long-term consequences. Front Med (Lausanne). 2015;2(2):1-10. Acceso: 06/01/2017.Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4325927/

  22. Sola A. Cuidados neonatales. Descubriendo la vida de un recién nacido enfermo. Displasia Broncopulmonar. Ediciones Médicas (Buenos Aires). 2011;2:1018-35.

  23. Lapcharoensap W, Gage S, Kan P, Profit J, Shaw G, Gould J, et al. Hospital Variation and risk factors for bronchopulmonary dysplasia in a population-based cohort. JAMA Pediatrics. 2015;169(2):1-07. Acceso: 26/05/2017. Disponible en: https://jamanetwork.com/journals/jamapediatrics/fullarticle/2108692

  24. Abman SH, Collaco JM, Shepherd EG, Keszler M, Cuevas-Guaman M, Welty SE, et al. Interdisciplinary care of Children with Severe 483 Bronchopulmonary Dysplasia. J Pediatr. 2017;181:12-28. Acceso: 10/09/2018. Disponible en: https://www.ncbi.nlm. nih.gov/pubmed/27908648

  25. Islam JY, Keller RL, Aschner JL, Hartert TV, Moore PE. Understanding the Shortand Long-Term Respiratory Outcomes of Prematurity and Bronchopulmonary Dysplasia. Am J Respir Crit Care Med. 2015; 92(2):134-56. Acceso: 11/09/2018. Disponible en: https://www.atsjournals.org/doi/abs/10.1164/rccm.201412-2142PP

  26. Gien J, Kinsella J, Thrasher J, Grenolds A, Abman SH, Baker CD. Retrospective Analysis of an Interdisciplinary ventilator care Program Intervention on Survival of Infants with Ventilator-Dependent Bronchopulmonary Dysplasia. Am J Perinatol. 2017;34(2):155-63. Acceso: 15/05/2018. Disponible en: https://www.ncbi. nlm.nih.gov/pubmed/27355979

  27. Sterni LM, Collaco JM, Baker CD, Carroll JL, Sharma GD, Brozek JL, et al. An Official American Thoracic Society Clinical Practice Guideline: Pediatric Chronic Home Invasive ventilation. Am J Respir Crit Care Med. 2016;193(8):e16-35. Acceso: 19/05/2018. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/27082538

  28. Fleiss JL. Statistical methods for rates and proportions. 2nd edition. New York: John Wiley & sons; 1981.

  29. Poindexter BB, Feng R, Schmidt B, Aschner JL, Ballard RA, Hamvas A, et al. Comparisons and Limitations of Current Definitions of Bronchopulmonary Dysplasia for the Prematurity and Respiratory Outcomes Program. Ann Am Thorac Soc. 2015;12(12):1822-30. Acceso: 11/12/2017. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/26397992

  30. Lal CV, Ambalavanan N. Genetic predisposition to bronchopulmonary dysplasia. Semin Perinatol. 2015;39(8):584-91. Acceso: 22/09/2018. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/26471063

  31. Guaman MC, Gien J, Baker CD, Zhang H, Austin ED, Collaco JM. Point Prevalence, Clinical Characteristics, and Treatment Variation for Infants with Severe Bronchopulmonary Dysplasia. Am J Perinatol. 2015;32(10):960-7. Acceso: 10/09/2018. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/25738785

  32. Lahra MM, Beeby PJ, Jeffery HE. Intrauterine inflammation, Neonatal Sepsis, and chronic lung disease: A 13-Year Hospital Cohort Study. Pediatrics. 2009;123(5):1314- 9. Acceso: 26/09/2015. Disponible en: https://www.ncbi.nlm.nih.gov/ pubmed/19403497

  33. Malleske D, Chorna O, Maitre M. Pulmonary sequelae and functional limitations in children and adults with bronchopulmonary displasia. Paediatr Respirat Rev. 2018; 26:55-9. Acceso: 19/06/2018. Disponible en: https://www.sciencedirect.com/science /article/pii/S1526054217300714

  34. Lapcharoensap W, Kan P, Powers RJ, Shaw GM, Stevenson DK, Gould JB, et al. The Relationship of Nosocomial Infection Reduction to Changes in Neonatal Intensive Care Unit Rates of Bronchopulmonary Dysplasia. J Pediatr. 2017; 180:105-9. Acceso: 26/12/2017. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/27742123

  35. Espitia- De La Hoz F. Diagnóstico y tratamiento de la corioamnionitis clínica. Rev colombiana Obstet Ginecol. 2008;59(3):231-7.

  36. Bancalari E. The Newborn Lung: Neonatology Questions and Controversies. 2nd edition. Philadelphia: ELSEVIER SAUNDERS; 2012.

  37. Lacaze-Masmonteil T. That chorioamnionitis is a risk factor for bronchopulmonary dysplasia-The case against. Paediatr Respirat Rev. 2014; 15(1):53-5. Acceso: 19/05/2015. Disponible en: https://doi.org/10.1016/j.prrv.2013.09.005

  38. Romero R, Nien JK, Espinoza J, Todem D, Fu W, Chung H, et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med. 2008;21(1):9-23. Acceso: 19/05/2015. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/18175241




2020     |     www.medigraphic.com